Results 121 to 130 of about 4,201 (171)

USO DEL TUMOR MUTATIONAL BURDEN COMO MARCADOR PREDICTIVO DE RESPUESTA AL TRATAMIENTO CON INMUNOTERAPIA

open access: yes
El tumor mutational Burden se utiliza como marcador predictivo de respuesta al tratamiento con inmunoterapia. Este con valores superiores a 10 Mut/Mb se vincula con mayores tasas de respuesta al tratamiento con inhibidores del punto de control ...
Borga, Guillermo   +5 more
core  

Application of Optical Genome Mapping for the Diagnosis and Risk Stratification of Myeloid and Lymphoid Malignancies. [PDF]

open access: yesInt J Mol Sci
Ballesta-Alcaraz L   +7 more
europepmc   +1 more source

[Asthma in the Canary Islands: Patient-Centered Derivation Criteria]. [PDF]

open access: yesOpen Respir Arch
González-Pérez R   +2 more
europepmc   +1 more source

[Our experience in the treatment of lymphatic malformations: Lessons learned and protocol]. [PDF]

open access: yesAn Sist Sanit Navar
Comajuncosas Pérez E   +3 more
europepmc   +1 more source

Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival. [PDF]

open access: yesBiol Res
Mora-Lagos B   +8 more
europepmc   +1 more source

NF-κB-dependent and independent inflammatory responses during acute HIV-1 infection in a model of human microglia. [PDF]

open access: yesFront Immunol
Gaete-Argel A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy